GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS

被引:0
|
作者
Tuomaala, A. -K. [1 ]
Varimo, T. [1 ]
Hakonen, E. [1 ]
Kiiveri, S. [1 ]
Janer, J. [1 ]
Hyvonen, M. [1 ]
Wehkalampi, K. [1 ]
Laakkonen, H. [1 ]
Laakso, S. [1 ]
Harsunen, M. [1 ]
Hero, M. [1 ]
Miettinen, P. [1 ]
Pulkkinen, M. -A. [1 ]
机构
[1] Helsinki Univ Hosp, HUS, Pediat & Adolescence, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP005 / #1
引用
收藏
页码:A82 / A82
页数:1
相关论文
共 50 条
  • [1] PARENTAL DIABETES INDUCED DISTRESS AFTER INITIATION OF MINIMED 780G SYSTEM IN SMALL CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS
    Pulkkinen, M. -A.
    Varimo, T.
    Hakonen, E.
    Tuomaala, A. -K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A2 - A3
  • [2] Evaluation of the MiniMed 780g system in young paediatric subjects (2-6 years old) with type 1 diabetes in a home setting: the Lenny study
    Cellot, J.
    Re, R.
    Gulotta, F.
    Lacroix, B.
    Vorrink, L.
    Di Piazza, F.
    Castaneda, J.
    Shin, J.
    Cohen, O.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 78 - 79
  • [3] Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
    Forlenza, Gregory P.
    Ekhlaspour, Laya
    DiMeglio, Linda A.
    Fox, Larry A.
    Rodriguez, Henry
    Shulman, Dorothy I.
    Kaiserman, Kevin B.
    Liljenquist, David R.
    Shin, John
    Lee, Scott W.
    Buckingham, Bruce A.
    PEDIATRIC DIABETES, 2022, 23 (03) : 324 - 329
  • [4] Glycemic Outcomes and Safety During the MiniMed™ 780G Advanced Hybrid Closed-Loop System in Egyptian Patients with Type 1 Diabetes
    Elbarbary, Nancy
    Shaarawy, Mohamed
    Selim, Esraa
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 185 - 186
  • [5] USE OF THE MEDTRONIC MINIMED 780G SYSTEM IN PREGNANCY IN TYPE 1 DIABETES
    Gardner, D. S.
    Chandran, S. Rama
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A116 - A116
  • [6] GLYCEMIC OUTCOMES DURING MINIMED 670G SYSTEM USE IN CHILDREN AGED 2-6 YEARS WITH T1D
    Lee, S. W.
    Shin, J.
    Cordero, T.
    Kaufman, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A20 - A20
  • [7] Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter
    Forlenza, Gregory P.
    MacLeish, Sarah A.
    Shulman, Dorothy I.
    Nwosu, Benjamin U.
    Accacha, Siham
    Garg, Satish K.
    Carlson, Anders L.
    Castorino, Kristin N.
    Marks, Brynn E.
    Lal, Rayhan
    Pihoker, Catherine
    Thrasher, James
    Laffel, Lori M.
    Sunil, Bhuvana
    Bode, Bruce W.
    Sherr, Jennifer L.
    Ekhlaspour, Laya
    Reed, John H.
    Abuzzahab, M. Jennifer
    Church, Mei Mei
    Dai, Zheng
    Ma, Haoxi
    Solomon, Jed
    Treminio, Yuri
    Shin, John
    Rhinehart, Andrew S.
    McVean, Jennifer
    Vigersky, Robert A.
    DIABETES, 2024, 73
  • [8] The LENNY Trial: The use of MINIMED 780G system in young pediatric users (2-6 years old) is safe and effective
    Battelino, T.
    Kuusela, S.
    Tuomalaa, A. -K.
    Shetty, A.
    Campbell, F.
    Rabbone, I.
    Cherubini, V.
    Re, R.
    Cellot, J.
    Gulotta, F.
    di Piazza, F.
    Shin, J.
    Cohen, O.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 61 - 61
  • [9] Safety and Metabolic Outcomes of Medtronic Minimed 780G Initiation at Diagnosis in Children and Adolescents
    Yilmaz, Ugur Cem
    Demir, Gunay
    Kizilay, Deniz Ozalp
    Ozen, Samim
    Goksen, Damla
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 674 - 675
  • [10] MiniMed 780g system and children with type 1 diabetes followed for one year: lessons learned from diabetes educators
    Almajaly, D.
    Petroviski, G.
    Rangarajan, R.
    Campbell, J.
    Pasha, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 354 - 354